This case traces the development of a balanced scorecard for the fast-growing biotech company in transition. It reads as new CEO embraces the concept of early indicators to explain and assess the progress of its strategic objectives for the different stakeholders. If subsequently traced the introduction and development of a system of indicators, as they are cascaded throughout the organization. Finally, the North American financial officer encounters a problem related performance goals for the performance of his individual goals finance team. "Hide
by Lawrence P. Carr Source: Babson College 13 pages. Publication Date: November 6, 2003. Prod. #: BAB043-PDF-ENG
Related Case Solutions & Analyses:
Mars Incorporated: Online Procurement
Arthur Andersen (C): The Collapse of Arthur Andersen
Danfoss Motion Controls And Holip (A) (Abridged)
Desso (B): Making It Happen—The Implementation Of A C2C Business Model
Do Star Performers Need To Network? (B): Re-Entry & Visibility: Bénédicte Foucart
Dr. Reddy’s: Medicine Is For People, Profits Follow
Elephant Dung And The Bioethanol Goldrush (B)
A Chronology of Integrated Reporting
National Electric Corp.
Maschinenbau Arrau AG (A)
